Generation Bio (GBIO)
(Delayed Data from NSDQ)
$2.78 USD
-0.08 (-2.80%)
Updated Sep 20, 2024 03:59 PM ET
After-Market: $2.81 +0.03 (1.08%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Generation Bio Co. (GBIO) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$7.50 | $10.00 | $5.00 | 162.24% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for Generation Bio Co. comes to $7.50. The forecasts range from a low of $5.00 to a high of $10.00. The average price target represents an increase of 162.24% from the last closing price of $2.86.
Analyst Price Targets (4 )
Broker Rating
Generation Bio Co. currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 42.86% and 14.29% of all recommendations. A month ago, Strong Buy made up 42.86%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 3 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
8/16/2024 | Canaccord Genuity | Whitney Ijem | Strong Buy | Strong Buy |
8/8/2024 | Wedbush Securities | David M Nierengarten | Strong Buy | Strong Buy |
5/14/2024 | Needham & Company | Gil J Blum | Moderate Buy | Moderate Buy |
1/24/2024 | JMP Securities | Silvan C Tuerkcan | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 7 |
Average Target Price | $7.50 |
LT Growth Rate | NA |
Industry | Medical - Biomedical and Genetics |
Industry Rank by ABR | 79 of 253 |
Current Quarter EPS Est: | -0.28 |
GBIO FAQs
Generation Bio Co. (GBIO) currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 7 brokerage firms.
The average price target for Generation Bio Co. (GBIO) is $7.50. The current on short-term price targets is based on 4 reports.
The forecasts for Generation Bio Co. (GBIO) range from a low of $5 to a high of $10. The average price target represents a increase of $169.78 from the last closing price of $2.78.
The current UPSIDE for Generation Bio Co. (GBIO) is 169.78%
Based on short-term price targets offered by four analysts, the average price target for Generation Bio Co. comes to $7.50. The forecasts range from a low of $5.00 to a high of $10.00. The average price target represents an increase of 162.24% from the last closing price of $2.86.